Title : HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail.

Pub. Date : 1988

PMID : 3145972






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Before treatment, 16 of 20 and 12 of 16 patients in the AZT and placebo groups, respectively, were p24 antigen positive. Zidovudine transmembrane p24 trafficking protein 2 Homo sapiens
2 Marked reduction in serum p24 levels were noted in 11 of 16 (69%) of the p24 antigen-positive AZT-treated patients compared to 3 of 12 (25%) of the p24 antigen-positive placebo-treated patients (p = 0.02). Zidovudine transmembrane p24 trafficking protein 2 Homo sapiens
3 Marked reduction in serum p24 levels were noted in 11 of 16 (69%) of the p24 antigen-positive AZT-treated patients compared to 3 of 12 (25%) of the p24 antigen-positive placebo-treated patients (p = 0.02). Zidovudine transmembrane p24 trafficking protein 2 Homo sapiens
4 Marked reduction in serum p24 levels were noted in 11 of 16 (69%) of the p24 antigen-positive AZT-treated patients compared to 3 of 12 (25%) of the p24 antigen-positive placebo-treated patients (p = 0.02). Zidovudine transmembrane p24 trafficking protein 2 Homo sapiens